113 related articles for article (PubMed ID: 9237794)
21. [Prostate Carcinoma Mimics Lung Carcinoma: A Case Report].
Drosos K; Höfner K
Aktuelle Urol; 2017 Apr; 48(2):153-155. PubMed ID: 28081573
[TBL] [Abstract][Full Text] [Related]
22. Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria.
Udeh EI; Nnabugwu II; Ozoemena FO; Ugwumba FO; Aderibigbe AS; Ohayi SR; Echetabu KN
World J Surg Oncol; 2016 Jun; 14(1):174. PubMed ID: 27356753
[TBL] [Abstract][Full Text] [Related]
23. [Detection of prostatic cancer in symptomatic patients with serum levels of prostate-specific antigen between 4 and 10 ng/ml].
Ravery V; Schmid HP; Billebaud T; Toublanc M; Boccon-Gibod L; Hermieu JF; Delmas V; Boccon-Gibod L
Presse Med; 1996 Feb; 25(7):272-6. PubMed ID: 8685164
[TBL] [Abstract][Full Text] [Related]
24. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.
Zeng L; Kyprianou N
Prostate Cancer Prostatic Dis; 2005; 8(1):7-13. PubMed ID: 15477876
[TBL] [Abstract][Full Text] [Related]
25. [Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases].
Chen DB; Shen DH; Zhang H; Wang Y; Song QJ; Yang SM; Fang XZ
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):775-781. PubMed ID: 29136691
[No Abstract] [Full Text] [Related]
26. Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density.
Schatteman PH; Hoekx L; Wyndaele JJ; Jeuris W; Van Marck E
Eur Urol; 2000 Apr; 37(4):404-12. PubMed ID: 10765070
[TBL] [Abstract][Full Text] [Related]
27. An unusual variant of prostatic adenocarcinoma with metastasis to testis. A case report.
Anila KR; Somanathan T; Mathews A; Jayasree K
Gulf J Oncolog; 2012 Jul; (12):73-6. PubMed ID: 22773221
[TBL] [Abstract][Full Text] [Related]
28. Bone metastases from prostate cancer without elevated prostate-specific antigen levels: diagnosis by anti-PSA immunostaining.
Berthelot JM; Gouin F; Denis M; Nomballais MF; Maugars Y; Blaive-Cervi S; Prost A
Rev Rhum Engl Ed; 1995 Jan; 62(1):54-5. PubMed ID: 7540487
[No Abstract] [Full Text] [Related]
29. PSMA/PSA ratio evaluated by immunohistochemistry may improve diagnosis of prostate cancer.
Jemaa AB; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Oueslati R
J Immunoassay Immunochem; 2014; 35(1):48-59. PubMed ID: 24063616
[TBL] [Abstract][Full Text] [Related]
30. Clinical Implication of Tests for Prostate-specific Antigen in Brain-dead Organ Donors.
Lee GW; Lee JM; Lee WJ; Kim YB; Min YG
Transplant Proc; 2018; 50(1):20-23. PubMed ID: 29407309
[TBL] [Abstract][Full Text] [Related]
31. Triple cancer: chronic lymphocytic leukemia with bladder and prostate carcinoma.
Gajendra S; Sharma R; Sahoo MK
Malays J Pathol; 2015 Aug; 37(2):159-63. PubMed ID: 26277675
[TBL] [Abstract][Full Text] [Related]
32. Minimum prostate-specific antigen (PSA) level diagnostic of prostate cancer.
Yesner R; Kelly LJ; Chan YK
Conn Med; 1996 Jul; 60(7):399-404. PubMed ID: 8758658
[TBL] [Abstract][Full Text] [Related]
33. Association of serum prostate-specific antigen levels with the results of the prostate needle biopsy.
Janbaziroudsari H; Mirzaei A; Maleki N
Bull Cancer; 2016 Sep; 103(9):730-4. PubMed ID: 27345449
[TBL] [Abstract][Full Text] [Related]
34. Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.
Perner S; Hofer MD; Kim R; Shah RB; Li H; Möller P; Hautmann RE; Gschwend JE; Kuefer R; Rubin MA
Hum Pathol; 2007 May; 38(5):696-701. PubMed ID: 17320151
[TBL] [Abstract][Full Text] [Related]
35. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
[TBL] [Abstract][Full Text] [Related]
36. CD5 immunostaining of lymphoid neoplasms in paraffin sections.
Butmarc J; Kourea HP; Kadin ME
Am J Clin Pathol; 1997 Apr; 107(4):496-7; author reply 497. PubMed ID: 9124221
[No Abstract] [Full Text] [Related]
37. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
Lane Z; Hansel DE; Epstein JI
Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
[TBL] [Abstract][Full Text] [Related]
38. Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma.
Kunju LP; Mehra R; Snyder M; Shah RB
Am J Clin Pathol; 2006 May; 125(5):675-81. PubMed ID: 16707367
[TBL] [Abstract][Full Text] [Related]
39. The risks of prostate cancer detection by transrectal ultrasound guide biopsy in Thai men with abnormal prostatic-specific antigen or abnormal digital rectal examination.
Leewansangtong S; Tantiwong A; Ratanarapee S; Nualyong C; Soontrapa S
J Med Assoc Thai; 2000 Dec; 83(12):1519-24. PubMed ID: 11253893
[TBL] [Abstract][Full Text] [Related]
40. [Status of PSA determination for early detection of prostate carcinoma].
Hammerer P; Huland H
Versicherungsmedizin; 1995 Jun; 47(3):83-6. PubMed ID: 7541925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
